89bio, Inc. (ETNB)

followers · Follow

Sector:

HEALTH CARE

Industry:

PHARMACEUTICALS

SIC:

PHARMACEUTICAL PREPARATIONS

CEO:

Rohan Palekar

Employees:

142 SANSOME STREET, SECOND FLOOR, SAN FRANCISCO, CA, 94104

(415) 432-9270

89bio.com

89bio, Inc. focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21.

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

89bio, Inc. YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available